[Study of 11 new cases of Kawasaki disease Congolese].
Kawasaki's disease (KD) is a rarely described entity in Africa. The purpose of this work is to describe the clinical, biological and evolutionary aspects of KD in the Congolese child. This is a retrospective study of 11 cases of KD collected from 2003 to 2014 at the University Hospital of Brazzaville. The diagnosis was based on the criteria proposed by the Mucocutaneous Lymph Node Syndrome Research Commitee and validated by the Center for Disease Control grouping the major criteria originally described by Kawasaki and updated by the American Heart Association. The sex-ratioM/F was 2.7 and the mean age of 16.5 ± 5.9 months (range 9 to 43 months). The average intake time was 12.8 ± 5.9 days (range 6 and 30). In nine cases there was a complete form. The symptoms began with an invasion of the upper airway in 8 cases. Achieving oropharyngeal was in the form of oral enanthema with strawberry tongue and / or angular cheilitis; it was associated with perineal erythema in 7 cases. Reaching the end realized swelling and/or redness and / or peeling finger gloves or flap toes. The latter occurred at an average of 11 ± 3.5 days (range 8 to 16) after the start of the fever. The treatment with acetylsalicylic acid administered to all children, began within varying between 4 and 15 days of admission. The defervescence was obtained after 5.3 ± 2.6 days (range 4 to 11). The average hospital stay was 16.6 ± 9.7 days (range: 11 to 25 days). The evolution after discharge was considered favorable in all cases. However, no control echocardiography was performed. KD remains an ubiquitous condition but with a variable incidence from one continent to another. The arrival of the twodimensional ultrasound should enable the systematic investigation of coronary abnormalities to catch up unnoticed past cases but also to prevent complications related there.
Faculté des sciences de la santé, Université Marien Ngouabi, Brazzaville, Congo. jmabialababela@yahoo.fr.|Service de pédiatrie nourrissons, CHU de Brazzaville, BP: 32, Brazzaville, Congo. jmabialababela@yahoo.fr.
J R
JR
Mabiala Babela
Faculté des sciences de la santé, Université Marien Ngouabi, Brazzaville, Congo.|Service de pédiatrie nourrissons, CHU de Brazzaville, BP: 32, Brazzaville, Congo.
L C
LC
Ollandzobo Ikobo
Faculté des sciences de la santé, Université Marien Ngouabi, Brazzaville, Congo.|Service de pédiatrie nourrissons, CHU de Brazzaville, BP: 32, Brazzaville, Congo.
R E
RE
Nika
Faculté des sciences de la santé, Université Marien Ngouabi, Brazzaville, Congo.|Service de pédiatrie nourrissons, CHU de Brazzaville, BP: 32, Brazzaville, Congo.
G
G
Moyen
D002675:Child, Preschool; D003223:Congo / Q000453:epidemiology; D057210:Delayed Diagnosis / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis / Q000453:epidemiology*; D010343:Patient Admission / Q000706:statistics & numerical data; D012189:Retrospective Studies
Acetylsalicylic acid; Child; Congo; Hospital; Kawasaki disease; Sub-Saharan Africa